End of Year Review: HPRA

This year has seen significant progress in several key areas of focus for the HPRA as we continued our work in response to the pandemic

By Danielle Norton December 20, 2022 Updated February 20, 2024 6 min read

This year has seen significant progress in several key areas of focus for the HPRA as we continued our work in response to the pandemic in combination with ongoing activities to ensure the successful implementation of new regulations and management of medicines shortages.

Written by Dr Lorraine Nolan, Chief Executive, Healthcare Products Regulatory Authority